Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
SynKinase
JNJ-38877605
CHF 0.00
In stock
SYN-1047-M0011 mgCHF 128.00
SYN-1047-M0055 mgCHF 184.00
SYN-1047-M01010 mgCHF 298.00
SYN-1047-M05050 mgCHF 1'064.00
SYN-1047-M100100 mgINQ
| Product Details | |
|---|---|
| Synonyms | JNJ38877605 |
| Product Type | Chemical |
| Properties | |
| Formula | C19H13F2N7 |
| MW | 377.4 |
| CAS | 943540-75-8 |
| Purity Chemicals | ≥95% |
| Appearance | Solid. |
| Solubility | Soluble in DMSO. Slightly soluble (<1mg/ml) in ethanol. |
| Declaration | Manufactured by SynKinase. |
| Other Product Data |
Target: c-MET | Kinase Group: RTK | Substrate: Tyrosine Click here for Original Manufacturer Product Datasheet Our product description may differ slightly from the original manufacturers product datasheet. |
| InChi Key | JRWCBEOAFGHNNU-UHFFFAOYSA-N |
| Shipping and Handling | |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Documents | |
| MSDS |
 Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Description
JNJ38877605 is an orally bio-available, small-molecule, c-MET tyrosine kinase inhibitor with potential anti-neoplastic activity. It is potent (c-MET enzyme and Phospho-MET IC(50) values of 4nM and 50nM, respectively) and highly specific (selective over 229 other kinases tested).
Product References
- MET and KRAS gene amplification mediates acquired resistance to MET tyrosine kinase inhibitors: V. Cepero, et al.; Cancer Res. 70, 7580 (2010)
- Targeting c-Met in melanoma: Mechanism of resistance and efficacy of novel combinatorial inhibitor therapy: D. Etnyre, et al.; Cancer Biol. Ther. 15, 1129 (2014)
Related Products
